Genotyping mice at 55% EBITDA - Acquisitions Anonymous 272
Genotyping mice at 55% EBITDA - Acquisitions Anonymous 272
In this episode of Acquisitions Anonymous, Michael and Heather discuss an investment opportunity in a genomic testing , specializing in...
Let us know if you enjoyed this episodeIn this episode of Acquisitions Anonymous, Michael and Heather discuss an investment opportunity in a genomic testing , specializing in DNA sequencing and genotyping for mice. Despite their initial unfamiliarity with the technical details, they recognize the company's significant role in pharmaceutical research. They are impressed by its financial performance, noting substantial growth in revenue and EBITDA, along with high margins. The conversation also...
Episode Transcript
More Episodes
Rerun Episode – Buying a Seasonal Christmas Tree Business in Utah
Interested in buying a franchise? Check out Connor's website here: https://connorgroce.com/lander
How to Find Hidden Specialty Pharmacy Deals – Broker Secrets Explained
In this episode the hosts dig into a $7.1 M cash‑price listing for a specialty pharmacy in Beverly Hills — evaluating its 1.49 M EBITDA, market position and regulatory complexity to see whether it’s a viable acquisition.
Inside an $11 M Elevator Services Deal: High Margin, Hard Growth
In this episode the hosts walk through evaluating a potential acquisition of a Houston‑area elevator services company, debating whether a 7.5× EBITDA asking price can pencil out given the financing constraints and growth challenges.